Literature DB >> 8902871

A possible central antinociceptive effect of dipyrone in mice.

H Akman1, F Aksu, I Gültekin, H Ozbek, U Oral, F Doran, F Baysal.   

Abstract

The antinociceptive effect of dipyrone, a nonsteroidal and inflammatory drug, was studied in a series of experiment employing tail-flick and hot-place models and the abdominal constrictor test. The drug was given via intracerebroventricular (i.c.v.), intrathecal (i.t.) or subcutaneous (s.c.) routes. Dipyrone exhibited no analgesic activity in the tail-flick and hotplate tests while it inhibited the number of stretches in a dose-dependent manner. The antinociceptive effect of dipyrone administered by the i.c.v. and i.t. routes was almost complete reversed by naloxone treatment. The same procedure attenuated but not completely inhibited the dipyrone action induced by s.c. administration. Histopathological examination revealed that i.t. dipyrone application produces no significant lesion in the spinal cord. The results suggest that dipyrone may exert a central antinociceptive action reversed by naloxone.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902871     DOI: 10.1159/000139417

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Effect of dipyrone and thalidomide alone and in combination on STZ-induced diabetic neuropathic pain.

Authors:  Neha Chauhan; Rajeev Taliyan; Pyare Lal Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-01-17       Impact factor: 3.000

2.  Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone.

Authors:  Pinar Elmas; Ahmet Ulugol
Journal:  J Neural Transm (Vienna)       Date:  2013-06-20       Impact factor: 3.575

3.  Non-opioid Analgesics and the Endocannabinoid System

Authors:  Ruhan Deniz Topuz; Özgur Gündüz; Çetin Hakan Karadağ; Ahmet Ulugöl
Journal:  Balkan Med J       Date:  2020-06-19       Impact factor: 2.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.